Hydroxyurea and sickle cell anemia: effect on quality of life

BACKGROUND: The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously showed that daily oral HU reduces painful sickle cell (SS) crises by 50% in patients with moderate to severe disease. The morbidity associated with this disease is known to have serious negative impact on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballas, Samir K, Barton, Franca B, Waclawiw, Myron A, Swerdlow, Paul, Eckman, James R, Pegelow, Charles H, Koshy, Mabel, Barton, Bruce A, Bonds, Duane R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569824/
https://www.ncbi.nlm.nih.gov/pubmed/16942629
http://dx.doi.org/10.1186/1477-7525-4-59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569824/
https://www.ncbi.nlm.nih.gov/pubmed/16942629
http://dx.doi.org/10.1186/1477-7525-4-59

Ejemplares similares